Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow-to-Debt Ratio
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow-to-Debt Ratio of 0.43x as of December 2025, meaning its operating cash flow of CN¥345.31 Million could theoretically repay 0% of its total liabilities (CN¥797.40 Million) in one year. See 300970 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. For the full cash flow conversion analysis, see 300970 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year debt coverage analysis for Jiangsu Hualv Biological Technology Co.Ltd.. Check Jiangsu Hualv Biological Technology Co.L earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.43x | CN¥345.31 Million | CN¥797.40 Million | ▲ +147.0% |
| 2024 | 0.18x | CN¥137.80 Million | CN¥786.12 Million | ▼ -42.0% |
| 2023 | 0.30x | CN¥166.67 Million | CN¥551.03 Million | ▼ -23.0% |
| 2022 | 0.39x | CN¥179.84 Million | CN¥457.83 Million | ▲ +107.5% |
| 2021 | 0.19x | CN¥83.08 Million | CN¥438.92 Million | ▼ -70.2% |
| 2020 | 0.63x | CN¥199.09 Million | CN¥313.67 Million | ▼ -16.8% |
| 2019 | 0.76x | CN¥213.96 Million | CN¥280.52 Million | — |